Characterization of the cardiovascular and behavioral effects of centrally administered neuropeptide K in the conscious rat.
Prat
A
A
Department of Physiology, Faculty of Medicine, Université de Montréal, Canada.
Picard
P
P
Regoli
D
D
Couture
R
R
D000595:Amino Acid Sequence; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D010134:Fenclonine / Q000031:analogs & derivatives / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D007276:Injections, Intraventricular; D008297:Male; D008969:Molecular Sequence Data; D009043:Motor Activity / Q000187:drug effects*; D015288:Neurokinin A / Q000037:antagonists & inhibitors; D009479:Neuropeptides / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013239:Stereotyped Behavior / Q000187:drug effects*; D015320:Tachykinins
D001549:Benzamides; D001713:Biphenyl Compounds; D009479:Neuropeptides; D009842:Oligopeptides; D010880:Piperidines; D015320:Tachykinins; C045206:neuropeptide K; C083382:R 487; C020261:4-chlorophenylalanine methyl ester; C073839:SR 48968; D015288:Neurokinin A; D010134:Fenclonine; C066892:CP 96345